Advice
in the absence of a submission from the holder of the marketing authorisation:
maraviroc (Celsentri®) is not recommended for use within NHS Scotland.
Indication under review: In combination with other antiretroviral medicinal products for treatment-experienced adolescents and children of 2 years and older and weighing at least 10kg infected with only CCR5-tropic HIV-1 detectable.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice68KB (PDF)
Medicine details
- Medicine name:
- maraviroc (Celsentri)
- SMC ID:
- 1282/17
- Indication:
- In combination with other antiretroviral medicinal products for treatment-experienced adolescents and children of 2 years and older and weighing at least 10kg infected with only CCR5-tropic HIV-1 detectable.
- Pharmaceutical company
- ViiV Healthcare/GSK
- BNF chapter
- Infections
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 09 October 2017